» Authors » Kanthi Kiran Kondepudi

Kanthi Kiran Kondepudi

Explore the profile of Kanthi Kiran Kondepudi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 87
Citations 811
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Das B, Basaiawmoit B, Sakure A, Sakure A, Maurya R, Bishnoi M, et al.
Curr Pharm Des . 2025 Feb; PMID: 40012285
Introduction: This study aims to valorise cheese whey waste by converting it into bioactive peptides that have several health benefits, potentially leading to the development of nutraceuticals and functional foods...
2.
Vadher K, Sakure A, Mankad P, Rawat A, Bishnoi M, Kondepudi K, et al.
J Sci Food Agric . 2025 Feb; PMID: 39893650
Background: This study aims to evaluate the antidiabetic and anti-inflammatory activities of Lacticaseibacillus rhamnosus (M9) MTCC 25516 during the fermentation of whey and soy protein isolates. It also seeks to...
3.
Kumar D, Bishnoi M, Kondepudi K, Sharma S
Probiotics Antimicrob Proteins . 2025 Jan; PMID: 39809955
Recent evidence links gut microbiota alterations to neurodegenerative disorders, including Parkinson's disease (PD). Replenishing the abnormal composition of gut microbiota through gut microbiota-based interventions "prebiotics, probiotics, synbiotics, postbiotics, and fecal...
4.
Pipaliya R, Basaiawmoit B, Sakure A, Maurya R, Bishnoi M, Kondepudi K, et al.
Food Chem . 2024 Dec; 468():142466. PMID: 39689486
The study assessed the peptide production by using potent Lactiplantibacillus plantarum KGL3A (MG722814) culture to ferment the sheep milk for evaluation of α-glucosidase inhibition, ACE inhibition, α-amylase inhibition, & inhibiting...
5.
Sodhi R, Kumar H, Singh R, Bansal Y, Kondepudi K, Bishnoi M, et al.
Eur J Pharmacol . 2024 Sep; 983:177010. PMID: 39299481
Aim: Metabolic comorbidities such as obesity type 2 diabetes, insulin resistance, glucose intolerance, dyslipidemia are the major contributors for lower life expectancy and reduced patient compliance during antipsychotic therapy in...
6.
Kamble M, Singh A, Singh S, Upadhyay A, Kondepudi K, Chinchkar A
Food Res Int . 2024 Aug; 192:114804. PMID: 39147504
This study investigated spray drying a method for microencapsulating Lacticaseibacillus rhamnosus GG using a gastrointestinal resistant composite matrix. An encapsulate composite matrix comprising green banana flour (GBF) blended with maltodextrin...
7.
Pipaliya R, Basaiawmoit B, Sakure A, Maurya R, Bishnoi M, Kondepudi K, et al.
J Sci Food Agric . 2024 Jun; PMID: 38855927
Background: The present study aimed to evaluate the anti-hypertensive and anti-diabetic activities from biologically active peptides produced by fermented sheep milk with Lacticaseibacillus paracasei M11 (MG027695), as well as to...
8.
Pipaliya R, Basaiawmoit B, Sakure A, Maurya R, Bishnoi M, Kondepudi K, et al.
Front Chem . 2024 May; 12:1389846. PMID: 38746020
This study investigated the synthesis of bioactive peptides from sheep milk through fermentation with KGL4 MTCC 25515 strain and assessed lipase inhibition, ACE inhibition, α-glucosidase inhibition, and α-amylase inhibition activities...
9.
Sodhi R, Kumar H, Singh R, Bansal Y, Singh Y, Kondepudi K, et al.
Biochem Pharmacol . 2024 Feb; 222:116074. PMID: 38395265
Olanzapine, a widely prescribed atypical antipsychotic, poses a great risk to the patient's health by fabricating a plethora of severe metabolic and cardiovascular adverse effects eventually reducing life expectancy and...
10.
Matta T, Bhatia R, Joshi S, Bishnoi M, Chopra K, Kondepudi K
3 Biotech . 2024 Feb; 14(3):62. PMID: 38344283
Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-024-03918-7.